AI is swooping in places to help diagnose certain eye conditions. Here, doctors weigh in on the AI eye health revolution's ...

A classic example of the coolness of eyewear, Marcello Mastroianni’s thick black glasses in 8 1/2 showed the world that an ...

A tribute to another star ophthalmologist.

Researchers from London's Moorfields Eye Hospital, biotech firm MeiraGTx and University College London have demonstrated that ...

UK shares outside the FTSE 100 and the FTSE 250 don’t get much attention. But there are some quality businesses that ...

National Vision Holdings, Inc. EYE is strengthening its foundation with leadership changes, expanded exam capacity and other strategic initiatives. Favorable optical retail industry statistics bode ...

With 25 games to go and a tight playoff race about to resume, interim coach Joe Sacco's Bruins gathered at Warrior Arena.

Clearside Biomedical, Inc. (NASDAQ:CLSD), currently valued at $81.15 million, is a biotechnology company focused on developing innovative therapies for blinding eye diseases using its proprietary SCS ...

Investors were digesting a busy week of tariff hikes and inflation updates, as fresh retail data and earnings reports rolled ...

China's biggest EV maker BYD this week unveiled a leap into driverless systems with its "God's Eye" system as it continues to ...

UBS thinks the AMP share price has risen too far. It has a sell rating on the business and a price target of $1.20. In other ...